Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,145 | -213,913 | -156,468 | -103,408 | -49,478 |
| Depreciation Amortization | 3,081 | 11,418 | 8,261 | 5,364 | 2,585 |
| Accounts receivable | 466 | -5,380 | -5,431 | -5,514 | -7,995 |
| Other Working Capital | 6,146 | -715 | -1,728 | -1,461 | -5,658 |
| Other Operating Activity | 2,232 | 29,189 | 23,809 | 16,735 | 13,686 |
| Operating Cash Flow | $-43,220 | $-179,401 | $-131,557 | $-88,284 | $-46,860 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -2,928 | -2,537 | -1,644 | -1,337 |
| Net Acquisitions | -5,000 | -20,000 | N/A | -20,000 | -20,000 |
| Purchase Sale Intangibles | N/A | N/A | -20,000 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -20,000 | 0 | 0 |
| Investing Cash Flow | $-5,000 | $-22,928 | $-22,537 | $-21,644 | $-21,337 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 28,000 | 5,000 | N/A | N/A | N/A |
| Debt Issued | N/A | 47,112 | 47,112 | 42,112 | 42,129 |
| Common Stock Issued | 13,325 | 6,723 | 447 | 5,853 | 116 |
| Common Stock Repurchased | N/A | -1,105 | -1,698 | -1,698 | -1,698 |
| Dividend Paid | -2,194 | -8,780 | -6,587 | -4,391 | -2,195 |
| Other Financing Activity | -16,944 | 26,369 | 17,427 | 11,079 | 11,612 |
| Financing Cash Flow | $22,187 | $75,319 | $56,701 | $52,955 | $49,964 |
| Beginning Cash Position | 180,954 | 307,964 | 307,964 | 307,964 | 307,964 |
| End Cash Position | 154,921 | 180,954 | 210,571 | 250,991 | 289,731 |
| Net Cash Flow | $-26,033 | $-127,010 | $-97,393 | $-56,973 | $-18,233 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,220 | -179,401 | -131,557 | -88,284 | -46,860 |
| Capital Expenditure | N/A | -3,055 | -2,664 | -1,644 | -1,337 |
| Free Cash Flow | -43,220 | -182,456 | -134,221 | -89,928 | -48,197 |